213 related articles for article (PubMed ID: 2106358)
1. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease.
Uebelhart D; Gineyts E; Chapuy MC; Delmas PD
Bone Miner; 1990 Jan; 8(1):87-96. PubMed ID: 2106358
[TBL] [Abstract][Full Text] [Related]
2. Changes with age in the urinary excretion of lysyl- and hydroxylysylpyridinoline, two new markers of bone collagen turnover.
Beardsworth LJ; Eyre DR; Dickson IR
J Bone Miner Res; 1990 Jul; 5(7):671-6. PubMed ID: 2118710
[TBL] [Abstract][Full Text] [Related]
3. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.
Garnero P; Gineyts E; Riou JP; Delmas PD
J Clin Endocrinol Metab; 1994 Sep; 79(3):780-5. PubMed ID: 8077361
[TBL] [Abstract][Full Text] [Related]
4. Urine products of bone breakdown as markers of bone resorption and clinical usefulness of urinary hydroxyproline: an overview.
Simsek B; Karacaer O; Karaca I
Chin Med J (Engl); 2004 Feb; 117(2):291-5. PubMed ID: 14975218
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases.
Robins SP; Black D; Paterson CR; Reid DM; Duncan A; Seibel MJ
Eur J Clin Invest; 1991 Jun; 21(3):310-5. PubMed ID: 1909635
[TBL] [Abstract][Full Text] [Related]
6. Specific changes of urinary excretion of cross-linked N-telopeptides of type I collagen in pre- and postmenopausal women: correlation with other markers of bone turnover.
Gorai I; Taguchi Y; Chaki O; Nakayama M; Minaguchi H
Calcif Tissue Int; 1997 Apr; 60(4):317-22. PubMed ID: 9075625
[TBL] [Abstract][Full Text] [Related]
7. High-performance liquid chromatographic determination of 3-hydroxypyridinium derivatives as new markers of bone resorption.
Kamel S; Brazier M; Desmet G; Picard C; Mennecier I; Sebert J
J Chromatogr; 1992 Feb; 574(2):255-60. PubMed ID: 1618957
[TBL] [Abstract][Full Text] [Related]
8. Changes with age in the urinary excretion of hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP).
Açil Y; Brinckmann J; Notbohm H; Müller PK; Bätge B
Scand J Clin Lab Invest; 1996 May; 56(3):275-83. PubMed ID: 8761532
[TBL] [Abstract][Full Text] [Related]
9. Galactosyl hydroxylysine in assessment of Paget's bone disease.
Michalsky M; Stepan JJ; Wilczek H; Formankova J; Moro L
Clin Chim Acta; 1995 Jan; 234(1-2):101-8. PubMed ID: 7758208
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of pyridinium crosslinks in postmenopausal women and in Paget's disease of bone.
Sinigaglia L; Varenna M; Binelli L; Beltrametti P; Zucchi F; Arrigoni M; Frignani S; Abbiati G
Calcif Tissue Int; 1997 Oct; 61(4):279-84. PubMed ID: 9312197
[TBL] [Abstract][Full Text] [Related]
11. Urinary excretion of pyridinium crosslinks of collagen in oophorectomized women as markers for bone resorption.
Hashimoto K; Nozaki M; Yokoyama M; Sano M; Nakano H
Maturitas; 1994 Feb; 18(2):135-42. PubMed ID: 8177094
[TBL] [Abstract][Full Text] [Related]
12. Bone-resorption markers galactosyl hydroxylysine, pyridinium crosslinks, and hydroxyproline compared.
Bettica P; Moro L; Robins SP; Taylor AK; Talbot J; Singer FR; Baylink DJ
Clin Chem; 1992 Nov; 38(11):2313-8. PubMed ID: 1424129
[TBL] [Abstract][Full Text] [Related]
13. Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone.
Adami S; Zamberlan N; Mian M; Dorizzi R; Rossini M; Braga B; Gatti D; Bertoldo F; Locascio V
Bone Miner; 1994 May; 25(2):75-82. PubMed ID: 8086853
[TBL] [Abstract][Full Text] [Related]
14. Different responses of free and peptide-bound cross-links to vitamin D and calcium supplementation in elderly women with vitamin D insufficiency.
Kamel S; Brazier M; Rogez JC; Vincent O; Maamer M; Desmet G; Sebert JL
J Clin Endocrinol Metab; 1996 Oct; 81(10):3717-21. PubMed ID: 8855828
[TBL] [Abstract][Full Text] [Related]
15. Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption.
Robins SP; Woitge H; Hesley R; Ju J; Seyedin S; Seibel MJ
J Bone Miner Res; 1994 Oct; 9(10):1643-9. PubMed ID: 7817812
[TBL] [Abstract][Full Text] [Related]
16. Urinary collagen crosslink excretion: a better index of bone resorption than hydroxyproline in Paget's disease of bone?
Hamdy NA; Papapoulos SE; Colwell A; Eastell R; Russell RG
Bone Miner; 1993 Jul; 22(1):1-8. PubMed ID: 8219934
[TBL] [Abstract][Full Text] [Related]
17. Effect of bisphosphonate therapy and parathyroidectomy on the urinary excretion of galactosylhydroxylysine in primary hyperparathyroidism.
LoCascio V; Braga V; Bertoldo F; Bettica P; Pasini AF; Stefani L; Moro L
Clin Endocrinol (Oxf); 1994 Jul; 41(1):47-51. PubMed ID: 8050131
[TBL] [Abstract][Full Text] [Related]
18. Urinary excretion level of hydroxylysylpyridinoline as an index of bone resorption.
Yoshihara K; Nemoto S; Nagata M
Biol Pharm Bull; 1994 Jun; 17(6):840-2. PubMed ID: 7951150
[TBL] [Abstract][Full Text] [Related]
19. Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation.
Krane SM; Kantrowitz FG; Byrne M; Pinnell SR; Singer FR
J Clin Invest; 1977 May; 59(5):819-27. PubMed ID: 404321
[TBL] [Abstract][Full Text] [Related]
20. Rapid method for the isolation of the mature collagen cross-links, hydroxylysylpyridinoline and lysylpyridinoline.
Açil Y; Müller PK
J Chromatogr A; 1994 Apr; 664(2):183-8. PubMed ID: 21941695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
